Table 2.
Outcomes | Data sources | PCochran’s Q | Pintercept | PMR-PRESSO global test |
---|---|---|---|---|
Coronary artery disease | CARDIoGRAMplusC4D | 0.477 | 0.537 | 0.474 |
FinnGen | 0.077 | 0.630 | 0.116 | |
Atrial fibrillation | Nielsen et al. | 0.162 | 0.321 | 0.103 |
FinnGen | 0.235 | 0.749 | 0.133 | |
Heart failure | HERMES | 0.667 | 0.443 | 0.586 |
FinnGen | 0.820 | 0.362 | 0.781 | |
Any stroke | MEGASTROKE | 0.778 | 0.274 | 0.771 |
FinnGen | 0.385 | 0.063 | 0.395 | |
Ischemic stroke | MEGASTROKE | 0.946 | 0.471 | 0.939 |
FinnGen | 0.042 | 0.006 | 0.052 | |
Large artery stroke | MEGASTROKE | 0.556 | 0.726 | 0.456 |
Small vessel stroke | MEGASTROKE | 0.194 | 0.029 | 0.244 |
Cardioembolic stroke | MEGASTROKE | 0.761 | 0.628 | 0.746 |
CARDIoGRAMplusC4D, Coronary ARtery DIsease Genome-wide Replication and Meta-analysis (CARDIoGRAM) plus The Coronary Artery Disease (C4D) Genetics; HERMES, Heart Failure Molecular Epidemiology for Therapeutic Targets.